Is MiMedx Group Inc (MDXG) Stock About to Get Hot Friday?

The market has been high on MiMedx Group Inc (MDXG) stock recently. MDXG gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

MiMedx Group Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on MDXG!

See Full MDXG Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With MDXG Stock Today?

MiMedx Group Inc (MDXG) stock is up 6.12% while the S&P 500 is down -0.08% as of 11:27 AM on Friday, Nov 17. MDXG is up $0.41 from the previous closing price of $6.70 on volume of 179,406 shares. Over the past year the S&P 500 is higher by 13.79% while MDXG is up 120.12%. MDXG lost -$0.02 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for MiMedx Group Inc click here.

More About MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties. Click Here to get the full Stock Report for MiMedx Group Inc stock.